NAD+ therapy (oral precursors or IV infusions of nicotinamide adenine dinucleotide) raises NAD+-related biomarkers in the body, but current evidence does not prove it slows or reverses aging in humans.
Oral precursors like NR and NMN have more clinical trial data than IV formulations, and IV NAD+ carries real safety risks tied to how it's compounded (Gallagher & Emmanuel, 2026).
No form of NAD+ is FDA-approved for anti-aging, and a January 2026 FDA warning letter highlights exactly what can go wrong when it's produced outside proper oversight (U.S. Food and Drug Administration, 2026).
What This Means
If you've seen NAD+ IV drips or supplements marketed as a way to "restore your cellular energy" or "turn back the clock," the honest picture is more modest.
NAD+ is a molecule your cells genuinely need for energy production and DNA repair, and levels do decline with age.
But needing NAD+ to function is different from proving that adding more of it from the outside meaningfully slows aging. Researchers who reviewed the available human trials in 2026 found that oral NAD+ precursors reliably raise NAD+ levels in the blood.
But the effects on how people actually feel, function, or age over the long term remain unclear (Gallagher & Emmanuel, 2026). IV NAD+ has even less rigorous human trial evidence behind it than oral forms.
Candidacy
NAD+ therapy is generally marketed to adults interested in energy, recovery, or general anti-aging support rather than to treat a diagnosed disease.
Reasonable candidates are typically healthy adults who understand the therapy is investigational, have no relevant contraindications, and are not using it as a substitute for treating an underlying medical condition.
The following groups should have their history reviewed carefully before considering NAD+ supplementation:
- People who are pregnant or breastfeeding.
- People with significant cardiovascular or kidney disease.
- People on medications with potential interactions.
Anyone with an active infection or unexplained symptoms should be evaluated for the underlying cause first, rather than starting NAD+ therapy to mask fatigue or low energy.
Clinical Evaluation
A responsible anti-aging or longevity evaluation looks at more than a single symptom. Clinics following current longevity-medicine frameworks typically start with a detailed medical history, a physical exam, and lab work covering thyroid and hormone panels, metabolic markers, and organ function before recommending any intervention.
This way, fatigue, poor recovery, or "brain fog" aren't mistakenly attributed to low NAD+ when they may have another cause (Mironov et al., 2024).
This evaluation step matters as much as the therapy itself, since it's what determines whether NAD+ is even a sensible option for a given patient.
Available Options
NAD+ is one tool among several used in anti-aging and longevity medicine, and it is rarely the only reasonable option. Conventional, well-established approaches remain the foundation:
- Optimizing sleep, exercise, and nutrition.
- Managing chronic conditions like diabetes or hypertension.
- Addressing diagnosed hormone deficiencies through hormone replacement therapy under physician supervision.
Within the NAD+ category, patients can choose between oral precursors (NR or NMN), which have more clinical trial data, and IV or injectable NAD+, which is typically compounded and carries different risks.
Other longevity-adjacent interventions sometimes discussed alongside NAD+, such as peptide therapies, have their own separate evidence bases and regulatory status and shouldn't be assumed to work the same way.
Benefits, Limitations & Risks
Benefits
Proponents point to real, biologically plausible mechanisms: NAD+ genuinely participates in cellular energy metabolism and DNA repair, and human trials have consistently shown that oral NAD+ precursors are safe to take for weeks to months and do raise NAD+-related blood markers (Gallagher & Emmanuel, 2026).
That's a real, if limited, benefit.
Limitations
The limitations are significant: no completed long-term human safety trials exist for NR or NMN, and evidence that raising NAD+ levels translates into measurable anti-aging benefits is still lacking (Gallagher & Emmanuel, 2026).
Risks
The risks are more concrete for IV and injectable NAD+.
A January 2026 FDA warning letter to a Florida compounding facility documented that improperly produced NAD+ injections led to three patients developing low blood pressure, uncontrollable shaking, and body aches, traced to excessive bacterial endotoxin contamination in a single vial (U.S. Food and Drug Administration, 2026).
That same facility compounded NAD+ using an ingredient not on FDA's approved compounding list, and a related NAD+ injection recall was separately classified Class I, the FDA's most serious category (Cleveland Clinic, 2026).
What the Evidence Shows
Current evidence does establish that NAD+ levels fall with age, that oral NAD+ precursors are reasonably well tolerated in short- to medium-term trials, and that they reliably raise NAD+-related biomarkers in blood (Radenkovic et al., 2020; Gallagher & Emmanuel, 2026).
What the evidence does not establish is that this biomarker change produces meaningful anti-aging outcomes in humans, whether IV NAD+ offers any advantage over oral forms, or what the risks of repeated long-term use might be (Gallagher & Emmanuel, 2026).
A 2026 PRISMA-guided systematic review of 33 human intervention studies found clinical and functional outcomes remain heterogeneous, with controlled outcomes evidence for parenteral (IV/injectable) NAD+ especially limited (Gallagher & Emmanuel, 2026). In short: the biochemistry is real, the anti-aging payoff is not yet proven.
Recovery / Next Steps
Oral NAD+ precursors typically involve no downtime. IV NAD+ infusions generally take one to three hours per session and can cause mild, infusion-related side effects such as flushing, nausea, headache, or chest tightness, which are usually related to how fast the infusion is given.
Anyone considering IV or injectable NAD+ should ask the provider directly:
- Where is the product sourced?
- Is it pharmaceutical-grade or food-grade?
- Is the compounding pharmacy properly registered?
These questions matter given the documented contamination risks with improperly produced formulations (U.S. Food and Drug Administration, 2026).
Orlando Considerations
Florida has a large concentration of wellness and IV-therapy clinics offering NAD+, and oversight quality varies by facility. Compounded sterile products used in IV NAD+ should come from a properly registered pharmacy or outsourcing facility, not an unregulated source.
Because the FDA's recent enforcement action involved a Florida-based compounder, Orlando-area patients considering NAD+ IV therapy should ask specifically about the sourcing and registration status of the product before proceeding.
Frequently Asked Questions
Is NAD+ therapy FDA-approved for anti-aging?
No. NAD+ is not FDA-approved to treat, cure, or prevent aging or any specific disease.
IV and injectable NAD+ products are generally compounded, which means they are not reviewed by the FDA for safety and effectiveness the way approved drugs are (U.S. Food and Drug Administration, 2026).
Is NAD+ IV therapy safe?
Oral NAD+ precursors have shown a reasonable short-to-medium-term safety profile in clinical trials.
IV NAD+ carries additional risk tied to sourcing and sterile compounding; the FDA has documented adverse events, including a Class I recall, linked to contaminated NAD+ injectable products (Cleveland Clinic, 2026; U.S. Food and Drug Administration, 2026).
How long does it take to see results from NAD+ therapy?
Some people report subjective energy changes within days of an IV infusion, but there's no established, evidence-backed timeline for anti-aging benefits, since long-term outcome data isn't yet available.
What's the difference between NAD+ IV therapy and NAD+ supplements?
Oral supplements (NR or NMN) have more human clinical trial data supporting their safety. IV NAD+ bypasses digestion for faster delivery but has far less rigorous outcome data and depends heavily on sourcing and compounding quality.
Can I combine NAD+ therapy with hormone replacement therapy?
That decision should be made with a licensed physician who can review your full history and labs, since combining interventions changes the risk-benefit calculation.
References
Cleveland Clinic. (2026, February 26). NAD+ supplements: Can they really slow down aging? https://health.clevelandclinic.org/nad-supplement
Gallagher, C., & Emmanuel, O. O. (2026). NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Research Reviews, 116, Article 103057. https://doi.org/10.1016/j.arr.2026.103057
Mironov, S., Borysova, O., Morgunov, I., Zhou, Z., & Moskalev, A. (2024). A framework for an effective healthy longevity clinic. Aging and Disease, 16(4), 1971-1986. https://doi.org/10.14336/AD.2024.0328-1
Radenkovic, D., Reason, & Verdin, E. (2020). Clinical evidence for targeting NAD therapeutically. Pharmaceuticals, 13(9), Article 247. https://doi.org/10.3390/ph13090247
U.S. Food and Drug Administration, Center for Drug Evaluation and Research. (2026, January 20). Warning letter: GenoGenix LLC (MARCS-CMS 718739). https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/genogenix-llc-718739-01202026
Last medically reviewed: August 07, 2026.
Related reading
- 7 Best Non Surgical Pain Treatments
- Best Treatments for Thinning Hair That Work
- Botox in Orlando: What to Know Before Your First Treatment
- How Medical Weight Loss Works
More questions answered on the PrimeCell patient blog, or see frequently asked questions.
Related services at PrimeCell
PrimeCell is a physician-led practice in Orlando. Candidacy for any procedure is determined at an in-person evaluation.
Ready when you are
Talk with a physician about your options
Have questions about whether this is right for you? Book a consultation with Dr. Chantasi, or call the clinic and we'll talk it through.
Orlando, FL · Mon–Fri 10am–6pm